JPRL

JPRL (Japan Pharmaceutical Research Laboratories) is a specialized pharmaceutical research and development company based in Japan, primarily operating as a subsidiary of Kowa Company, Ltd. The company focuses on the discovery and early-stage development of small molecule therapeutics across various therapeutic areas, including cardiovascular and metabolic diseases. JPRL is notably recognized for its contributions to the development of pitavastatin (Livalo), a potent HMG-CoA reductase inhibitor used globally for the treatment of hypercholesterolemia. By leveraging its expertise in medicinal chemistry and pharmacology, JPRL continues to support Kowa's broader pharmaceutical pipeline through innovative drug discovery efforts.